Guardant Health Inc [GH] stock prices are up 0.13% to $97.84 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The GH shares have gain 2.94% over the last week, with a monthly amount glided 56.39%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Guardant Health Inc [NASDAQ: GH] stock has seen the most recent analyst activity on September 25, 2025, when Wolfe Research upgraded its rating to a Outperform but kept the price target unchanged to $75 for it. On April 10, 2025, Mizuho initiated with a Outperform rating and assigned a price target of $55 on the stock. Barclays started tracking the stock assigning a Overweight rating and suggested a price target of $60 on January 23, 2025. Guggenheim upgraded its rating to a Buy but $36 remained the price target by the analyst firm on June 28, 2024.
The stock price of Guardant Health Inc [GH] has been fluctuating between $28.45 and $101.57 over the past year. Currently, Wall Street analysts expect the stock to reach $88.89 within the next 12 months. Guardant Health Inc [NASDAQ: GH] shares were valued at $97.84 at the most recent close of the market. An investor can expect a potential drop of -9.15% based on the average GH price forecast.
Analyzing the GH fundamentals
The Guardant Health Inc [NASDAQ:GH] reported sales of 902.57M for trailing twelve months, representing a surge of 38.50%. Gross Profit Margin for this corporation currently stands at 0.64% with Operating Profit Margin at -0.49%, Pretax Profit Margin comes in at -0.44%, and Net Profit Margin reading is -0.44%. To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is 1.52 and Total Capital is -0.43. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -3.67.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 95.49 points at the first support level, and at 93.14 for the second support level. However, for the 1st resistance point, the stock is sitting at 99.96, and for the 2nd resistance point, it is at 102.08.
Ratios To Look Out For
It’s worth pointing out that Guardant Health Inc [NASDAQ:GH]’s Current Ratio is 3.50. Further, the Quick Ratio stands at 3.12, while the Cash Ratio is 2.45. Considering the valuation of this stock, the price to sales ratio is 14.02.
Transactions by insiders
Recent insider trading involved Hidalgo Medina Manuel, Director, that happened on Nov 07 ’25 when 1500.0 shares were sold. Chief Legal Officer, Saia John G. completed a deal on Nov 07 ’25 to sell 8996.0 shares. Meanwhile, Director Hidalgo Medina Manuel bought 1500.0 shares on Nov 07 ’25.
